Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-Stage Small Cell Lung Cancer: PEERS Phase 2 Trial
N. Reguart Aransay, I. Victoria, J. L. Marti, E. Carcereny, H. Arasanz, M. Domine, N. Fernandez,M. A. Sala, E. Marin, E. Sanfeliu, A. Arcocha,D. Martinez, R. Reyes,A. Navarro, A. Barba, R. Garcia-Campelo, J. Giner, A. Blasco,E. Sais, V. Gutierrez, R. Marse, P. Martin, J. Zugazagoita, B. Salinas, S. Cobo, M. Provencio JOURNAL OF THORACIC ONCOLOGY(2023)
关键词
ES-SCLC,Lenvatinib,Pembrolizumab
AI 理解论文
溯源树
样例